Efficacy of repeat-dose rituximab maintenance therapy for minimal change disease in adults

被引：0
|
作者：
Shinya Taguchi
Takayasu Ohtake
Yasuhiro Mochida
Kunihiro Ishioka
Hidekazu Moriya
Sumi Hidaka
Shuzo Kobayashi
机构：
[1] Shonan Kamakura General Hospital,Kidney Disease and Transplant Center
来源：
Clinical and Experimental Nephrology | 2020年 / 24卷
关键词：
Minimal change disease; Nephrotic syndrome; Relapse; Rituximab; B-cell depletion; Steroid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1132 / 1139
页数：7
相关论文
共 50 条
  • [41] Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysis
    Xue, Cheng
    Yang, Bo
    Xu, Jing
    Zhou, Chenchen
    Zhang, Liming
    Gao, Xiang
    Dai, Bing
    Yu, Shengqiang
    Mao, Zhiguo
    Mei, Changlin
    Xu, Chenggang
    CLINICAL KIDNEY JOURNAL, 2021, 14 (04) : 1042 - 1054
  • [42] Rituximab Treatment for Relapsing Minimal Change Disease and Focal Segmental Glomerulosclerosis: A Systematic Review
    Kronbichler, Andreas
    Kerschbaum, Julia
    Fernandez-Fresnedo, Gema
    Hoxha, Elion
    Kurschat, Christine E.
    Busch, Martin
    Bruchfeld, Annette
    Mayer, Gert
    Rudnicki, Michael
    AMERICAN JOURNAL OF NEPHROLOGY, 2014, 39 (04) : 322 - 330
  • [43] Efficacy of cyclosporine combination therapy for new-onset minimal change nephrotic syndrome in adults
    Fujiwara, Akira
    Hirawa, Nobuhito
    Kobayashi, Yusuke
    Yatsu, Keisuke
    Katsumata, Mari
    Ehara, Yohsuke
    Okuyama, Yuki
    Yutoh, Jun
    Kaneda, Tomoko
    Fujita, Megumi
    Yamamoto, Yuichiro
    Saka, Sanae
    Toya, Yoshiyuki
    Yasuda, Gen
    Umemura, Satoshi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2015, 19 (02) : 240 - 246
  • [44] Case report: Effective treatment of rituximab-resistant minimal change disease with obinutuzumab in an adult
    Wang, Qiang
    Lin, Lin
    Zhen, Junhui
    Jiang, Bei
    Liu, Guangyi
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [45] Minimal Change Disease After First Dose of Pfizer-BioNTech COVID-19 Vaccine: A Case Report and Review of Minimal Change Disease Related to COVID-19 Vaccine
    Hanna, Jessica
    Ingram, Alistair
    Shao, Tiffany
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2021, 8
  • [46] Morphological Features of Minimal Change Disease and Focal Segmental Glomerulosclerosis Using Repeat Biopsy and Parietal Epithelial Cell Marker
    Suzuki, Tomo
    Kohatsu, Kaori
    Han, Wei
    Watanabe, Shiika
    Yahagi, Koichi
    Nakata, Mayumi
    Ueno, Toshiharu
    Ichikawa, Daisuke
    Imai, Naohiko
    Shirai, Sayuri
    Koike, Junki
    Shibagaki, Yugo
    KIDNEY DISEASES, 2020, 6 (02) : 119 - 124
  • [47] Efficacy and safety of rituximab induction therapy and effect of rituximab maintenance for IgG4-related disease: a systematic review and meta-analysis
    Liu, Yixiao
    Jin, Kehan
    Yang, Yingyun
    Yang, Aiming
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 127 : 63 - 73
  • [48] Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis—a case series
    A. Knight
    H. Hallenberg
    E. Baecklund
    Clinical Rheumatology, 2014, 33 : 841 - 848
  • [49] Interventions for minimal change disease in adults with nephrotic syndrome
    Azukaitis, Karolis
    Palmer, Suetonia C.
    Strippoli, Giovanni F. M.
    Hodson, Elisabeth M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (03):
  • [50] Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult:: First case report and pathophysiological considerations
    Francois, Helene
    Daugas, Eric
    Bensman, Albert
    Ronco, Pierre
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (01) : 158 - 161
12345